Monoclonal Antibodies: Casirivimab and Imdevimab
Amidst the emerging third wave of COVID, researchers suggest using monoclonal antibodies-Casirimivab and Imdevimab in comorbid patients.
Dr. Achanta Krishna Swaroop
